Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inhibitor or Reverse Transcriptases or of RNA-dIrected DNA polymerase.
| Descriptor ID |
D000068257
|
| MeSH Number(s) |
D02.705.429.906.125 D03.383.533.375 D03.383.742.680.245.500.600.125 D03.633.100.759.138.881.125 D26.310.375
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination".
- Chemicals and Drugs [D]
- Organic Chemicals [D02]
- Organophosphorus Compounds [D02.705]
- Organophosphonates [D02.705.429]
- Tenofovir [D02.705.429.906]
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D02.705.429.906.125]
- Heterocyclic Compounds [D03]
- Heterocyclic Compounds, 1-Ring [D03.383]
- Oxazines [D03.383.533]
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.533.375]
- Pyrimidines [D03.383.742]
- Pyrimidine Nucleosides [D03.383.742.680]
- Cytidine [D03.383.742.680.245]
- Deoxycytidine [D03.383.742.680.245.500]
- Emtricitabine [D03.383.742.680.245.500.600]
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.125]
- Heterocyclic Compounds, Fused-Ring [D03.633]
- Heterocyclic Compounds, 2-Ring [D03.633.100]
- Purines [D03.633.100.759]
- Adenine [D03.633.100.759.138]
- Tenofovir [D03.633.100.759.138.881]
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.125]
- Pharmaceutical Preparations [D26]
- Drug Combinations [D26.310]
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D26.310.375]
Below are MeSH descriptors whose meaning is more specific than "Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination".
This graph shows the total number of publications written about "Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" by people in this website by year, and whether "Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" by people in Profiles.
-
Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment. AIDS Res Hum Retroviruses. 2018 11; 34(11):907-908.